D’Amico, G. et al. Clinical states of cirrhosis and competing risks. J. Hepatol. 68, 563–576 (2018).

Article  PubMed  Google Scholar 

Villanueva, C. et al. Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 393, 1597–1608 (2019). The first RCT to show that β-blockers prevent decompensation and improve survival in patients with compensated cirrhosis.

Article  CAS  PubMed  Google Scholar 

Villanueva, C. et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J. Hepatol. 77, 1014–1025 (2022). A recent individual patient data meta-analysis showing that carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis.

Article  CAS  PubMed  Google Scholar 

Hytiroglou, P. et al. Beyond “cirrhosis”: a proposal from the International Liver Pathology Study Group. Am. J. Clin. Pathol. 137, 5–9 (2012).

Article  PubMed  Google Scholar 

Asesio, N. et al. Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis. Dig. Liver Dis. 54, 645–653 (2022).

Article  CAS  PubMed  Google Scholar 

Jachs, M. et al. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. J. Hepatol. 80, 744–752 (2024).

Article  CAS  PubMed  Google Scholar 

Jindal, A., Sarin, S. K., Kumar, M. & Kumar, G. Clinical outcomes in patients with advanced chronic liver disease and hepatic venous pressure gradient ≤10 mm Hg. Dig. Dis. Sci. 67, 5280–5289 (2022).

Article  CAS  PubMed  Google Scholar 

Jindal, A. et al. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria. Hepatol. Int. 16, 89–98 (2022).

Article  PubMed  Google Scholar 

Kobayashi, T. et al. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. J. Gastroenterol. 59, 56–65 (2024).

Article  PubMed  Google Scholar 

Lin, H. et al. Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: a competing risk analysis. Aliment. Pharmacol. Ther. 58, 920–928 (2023).

Article  CAS  PubMed  Google Scholar 

Schneider, A. R. P. et al. Early prediction of decompensation (EPOD) score: non-invasive determination of cirrhosis decompensation risk. Liver Int. 42, 640–650 (2022).

Article  PubMed  Google Scholar 

Semmler, G. et al. Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease. Gastroenterology 165, 1041–1052 (2023).

Article  PubMed  Google Scholar 

Shearer, J. E., Jones, R., Parker, R., Ferguson, J. & Rowe, I. A. The natural history of advanced chronic liver disease defined by transient elastography. Clin. Gastroenterol. Hepatol. 21, 694–703.e8 (2023).

Article  PubMed  Google Scholar 

Song, B. G. et al. Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII. Liver Int. 43, 1966–1974 (2023).

Article  CAS  PubMed  Google Scholar 

Thorhauge, K. H. et al. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease. J. Hepatol. 81, 23–32 (2024).

Article  PubMed  Google Scholar 

Wong, Y. J. et al. Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients. Hepatology https://doi.org/10.1097/HEP.0000000000000891 (2024).

Wong, Y. J. et al. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin. Mol. Hepatol. 29, 135–145 (2023).

Article  PubMed  Google Scholar 

Hai, Y., Chong, W., Eisenbrey, J. R. & Forsberg, F. Network meta-analysis: noninvasive imaging modalities for identifying clinically significant portal hypertension. Dig. Dis. Sci. 67, 3313–3326 (2022).

Article  PubMed  Google Scholar 

Berzigotti, A. et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144, 102–111.e1 (2013).

Article  PubMed  Google Scholar 

Groszmann, R. J. et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med. 353, 2254–2261 (2005). A seminal RCT defining CSPH.

Article  CAS  PubMed  Google Scholar 

Ripoll, C. et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133, 481–488 (2007).

Article  CAS  PubMed  Google Scholar 

Berzigotti, A. et al. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension. J. Gastroenterol. 46, 687–695 (2011).

Article  PubMed  Google Scholar 

Tsochatzis, E. A., Bosch, J. & Burroughs, A. K. Liver cirrhosis. Lancet 383, 1749–1761 (2014).

Article  PubMed  Google Scholar 

Arroyo, V. & Jalan, R. Acute-on-chronic liver failure: definition, diagnosis, and clinical characteristics. Semin. Liver Dis. 36, 109–116 (2016).

Article  PubMed  Google Scholar 

D’Amico, G. et al. Further decompensation in cirrhosis: results of a large multicenter cohort study supporting Baveno VII statements. Hepatology 79, 869–881 (2024).

Article  PubMed  Google Scholar 

Garcia-Guix, M. et al. Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: the role of portal hypertension and HVPG changes. Liver Int. 44, 1971–1989 (2024).

Article  CAS  PubMed  Google Scholar 

D’Amico, G., Bernardi, M. & Angeli, P. Towards a new definition of decompensated cirrhosis. J. Hepatol. 76, 202–207 (2022).

Article  PubMed  Google Scholar 

Tonon, M. et al. A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis. J. Hepatol. 80, 603–609 (2024).

Article  PubMed  Google Scholar 

Artru, F. & Reiberger, T. One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis. J. Hepatol. 80, 537–539 (2024).

Article  PubMed  Google Scholar 

Moreau, R. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144, 1426–1437.e9 (2013).

Article  PubMed  Google Scholar 

Trebicka, J. et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J. Hepatol. 73, 842–854 (2020).

Article  PubMed  Google Scholar 

de Franchis, R. et al. Baveno VII – Renewing consensus in portal hypertension. J. Hepatol. 76, 959–974 (2022). A comprehensive consensus document that has led to change in clinical practice and encouraged further research.

Article  PubMed  Google Scholar 

Rockey, D. C. & Friedman, S. L. Fibrosis regression after eradication of hepatitis C virus: from bench to bedside. Gastroenterology 160, 1502–1520.e1 (2021).

Article  CAS  PubMed  Google Scholar 

Harrison, S. A. et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N. Engl. J. Med. 390, 497–509 (2024).

Article  PubMed  Google Scholar 

Loomba, R. et al. Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N. Engl. J. Med. 391, 299–310 (2024).

Article  CAS  PubMed  Google Scholar